HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sipuleucel-T (Provenge®) for castration-resistant prostate cancer.

AuthorsOliver Sartor
JournalBJU international (BJU Int) Vol. 110 Issue 2 Pt 2 Pg. E105 (Jul 2012) ISSN: 1464-410X [Electronic] England
PMID22176510 (Publication Type: Editorial, Comment)
Chemical References
  • Cancer Vaccines
  • Tissue Extracts
  • sipuleucel-T
Topics
  • Cancer Vaccines (therapeutic use)
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy)
  • Tissue Extracts (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: